Arcus biosciences to participate in the 43rd annual j.p. morgan healthcare conference

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, announced that terry rosen, ph.d., chief executive officer, will present at the upcoming 43rd annual j.p. morgan healthcare conference in san francisco, ca. the presentation will take place on tuesday, january 14th, 2025, at 3:45pm pt. a live webcast of the presentation will be avail.
RCUS Ratings Summary
RCUS Quant Ranking